Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis : JACC: CardioOncology State-of-the-Art Review

ABSTRACT: Cardiovascular disease and cancer are the 2 leading causes of death worldwide. Emerging evidence suggests common mechanisms between cancer and cardiovascular disease, including atrial fibrillation and atherosclerosis. With advances in cancer therapies, screening, and diagnostics, cancer-specific survival and outcomes have improved. This increase in survival has led to the coincidence of cardiovascular disease, including atrial fibrillation and atherosclerosis, as patients with cancer live longer. Additionally, cancer and cardiovascular disease share several risk factors and underlying pathophysiologic mechanisms, including inflammation, cancer-related factors including treatment effects, and alterations in platelet function. Patients with cancer are at increased risk for bleeding and thrombosis compared with the general population. Although optimal antithrombotic therapy, including agent choice and duration, has been extensively studied in the general population, this area remains understudied in patients with cancer despite their altered thrombotic and bleeding risk. Future investigation, including incorporation of cancer-specific characteristics to traditional thrombotic and bleeding risk scores, clinical trials in the cancer population, and the development of novel antithrombotic and anti-inflammatory strategies on the basis of shared pathophysiologic mechanisms, is warranted to improve outcomes in this patient population. Central Illustration Highlights • Cancer and cardiovascular disease increasingly coexist, and patients with cancer are often undertreated.• Cancer and cardiovascular disease share common pathophysiology, including inflammation.• Thrombosis and bleeding risk scores often underperform in patients with cancer and cardiovascular disease.• Inclusion of cancer status in cardiovascular trials and risk scores may improve cardiovascular outcomes.

SUBMITTER: Leiva O 

PROVIDER: S-EPMC8702799 | biostudies-literature |

REPOSITORIES: biostudies-literature